Newborn screening for deafness genes with cord blood-based multicolour melting curve analysis

Xianning Dai1, Kai Xu1, Liya Dai1

  • 1Department of Clinical Laboratory, Wenzhou People's Hospital, Wenzhou Women and Children's Hospital, Zhejiang, China.

PubMed

Insights

Simultaneous newborn screening for hearing and deafness genes in Southeast China identified significant variant prevalence. This approach supports genetic counseling and early diagnosis for sensorineural hearing impairment.

Area of Science:

  • Genetics
  • Audiology
  • Neonatal Medicine

Background:

  • Neonatal screening for hearing and genetic factors is crucial for early intervention.
  • Understanding the prevalence of deafness-related gene variants in specific populations is essential.

Purpose of the Study:

  • To determine the prevalence of simultaneous hearing and genetics screening in neonates.
  • To provide evidence for the utility of newborn screening in Southeast China.

Main Methods:

  • 27,843 neonates underwent otoacoustic emissions (hearing) and genetic testing for deafness gene variants (GJB2, GJB3, SLC26A4, MTRNR1) using multicolour melting curve analysis.
  • Data from June 2015 to March 2023 were analyzed.

Main Results:

  • 0.88% failed hearing screening; 4.69% had at least one deafness gene variant.
  • GJB2 c.235delC and SLC26A4 c.919-2 A > G were the most common variants.
  • A statistically significant difference in variant rates was observed between hearing-screened groups.

Conclusions:

  • Cord blood-based melting curve analysis is effective for newborn screening of deafness genes.
  • This method aids genetic counseling, prenatal diagnosis, and screening for unknown sensorineural hearing impairment.
  • The PCR melting curve analysis is cost-effective, convenient, and suitable for clinical application.
Abstract